SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is facing significant selling pressure as investors react to a heavy capital expenditure outlook and a substantial decline in free cash flow, despite achieving strong double-digit revenue growth. The community is sharply divided, with bulls viewing the pullback as an accumulation opportunity based on the company's advertising cash flow, while bears are expressing intense frustration over management's aggressive AI spending and the perceived lack of tangible returns.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending following the broad approval of its drug Anktiva by the UAE, which serves as a major medical tourism hub and validates the company's global expansion strategy. Community discussion is focused on the potential for this regulatory milestone to drive immediate revenue and create pressure on short sellers ahead of upcoming quarterly earnings.

Stellantis NV engages in the designing, engineering, manufacturing, distributing, and selling of vehicles and components. It offers its products under the Abarth, Alfa Romeo, Chrysler, Citroën, Dodge, DS Automobiles, Fiat, Jeep, Lancia, Maserati, Opel, Peugeot, Ram Trucks, Vauxhall, Free2move, and Leasys brands. The company was founded on April 1, 2014 and is headquartered in Hoofddorp, the Netherlands.

Stellantis N.V

Stellantis is trending as investors weigh its deep value potential and aggressive $70 billion restructuring plan against intense competition and macroeconomic headwinds. The community is actively debating the company's turnaround viability, with many highlighting its undervalued market cap relative to strong cash reserves and iconic brand portfolio, while others remain cautious due to ongoing margin pressures and global supply chain challenges.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is experiencing intense selling pressure amid growing concerns over geopolitical tensions in the Middle East, rising bond yields, and investor skepticism regarding the long-term profitability of aggressive AI capital expenditures. The community is actively debating whether the recent market weakness is a systemic shift or a temporary correction, with many traders focusing on the volatility in semiconductor stocks and the influence of international market trends on domestic performance.

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. The company's products include Tavalisse, Fostamatinib and R835. Rigel Pharmaceuticals was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.

Rigel Pharmaceuticals

Rigel Pharmaceuticals is currently a focal point for investors as they transition from a hematology-focused firm to an oncology growth company following the acquisition of the FDA-approved breast cancer treatment, VEPPANU. The community is actively discussing the potential for a short squeeze given the high short interest and limited float, while closely monitoring the company's profitability and upcoming commercial launch milestones.

Starbucks Corp. engages in the production, marketing, and retailing of specialty coffee. It operates through the following segments: North America, International, and Channel Development. The North America segment focuses on the United States and Canada. The International segment is involved in China, Japan, Asia Pacific, Europe, Middle East, Africa, Latin America, and Caribbean. The Channel Development segment includes roasted whole bean and ground coffees, Seattle’s Best Coffee, and Teavana-branded single-serve products. The company was founded by Jerry Baldwin and Howard D. Schultz on November 4, 1985, and is headquartered in Seattle, WA.

Starbucks Corp.

Starbucks Corp

Starbucks stock is rallying after a fiscal third-quarter report that topped revenue and earnings expectations, signaling that CEO Brian Niccol's "Back to Starbucks" turnaround strategy is gaining traction. The community is actively debating whether the stock's recent price appreciation already reflects this recovery or if there is further upside potential as the company improves store operations and raises its full-year outlook.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The SPDR S&P 500 ETF Trust is currently experiencing heightened volatility as market participants weigh strong earnings from mega-cap tech companies against intensifying geopolitical tensions in the Middle East and concerns over rising bond yields. Community discussions are heavily focused on navigating the erratic price swings, with investors debating whether recent dips represent a buying opportunity or the beginning of a deeper correction driven by macro-economic headwinds.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is experiencing intense volatility and downward pressure as investors rotate out of the semiconductor sector, fueled by broader macro concerns over AI capital expenditure sustainability and geopolitical tensions. Despite strong recent earnings, the community remains divided between those viewing the pullback as a long-term accumulation opportunity and those frustrated by aggressive short-selling and perceived market manipulation.

Rolls-Royce Holdings Plc designs, develops, manufactures, and services integrated power systems for use in the air, on land, and at sea. The company operates its business through following segments: Civil Aerospace, Power Systems, Defense and New Markets. The Civil Aerospace segment offers commercial aero engines and aftermarket services. The Power Systems segment includes engines, power systems and nuclear systems for civil power generation. The Defense segment consists of military aero engines, naval engines, submarines and aftermarket services. The New Markets segment includes development, manufacture and sales of small modular reactors (SMRs) and new electrical power solutions. The company was founded in March 1906 and is headquartered in London, the United Kingdom.

Rolls-Royce Holdings Plc - ADR

Rolls-Royce is trending as investors react to exceptionally strong half-year financial results, highlighted by significant revenue and profit growth alongside increased full-year guidance. The community is actively discussing the company's robust performance across all divisions, the momentum behind its small modular reactor (SMR) initiatives, and the long-term potential for sustained growth.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Biocryst Pharmaceuticals is seeing increased investor activity and price momentum driven by renewed market speculation regarding potential M&A activity following recent industry deals. While retail traders are actively debating whether this is the start of a sustained breakout or another period of market manipulation, the community is closely monitoring the stock's significant short interest and upcoming earnings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$AON declared a $0.82 quarterly cash dividend per share. Another steady shareholder-return move from the risk/human capital name. No surprise here, but it reinforces the cash-generating profile and the income angle on the stock.

StockTwits Web

Aon plc. - Ordinary Shares - Class A

 declared a $0.82 quarterly cash dividend per share. Another steady shareholder-return move from the risk/human capital name. No surprise here, but it reinforces the cash-generating profile and the income angle on the stock.